Label: NAUZENE CHEWABLES GINGER HONEY- sodium citrate tablet, chewable

  • NDC Code(s): 52389-677-42
  • Packager: Kobayashi Healthcare International, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated June 24, 2025

If you are a consumer or patient please visit this version.

  • Active ingredient (in each cheable tablet)

    Sodium citrate dihydrate 230 mg

  • Purpose

    Antacid

  • Uses

    For the relief of heartburn, sour stomach, acid indigestion, and upset stomach and accompanying nausea associated with overindulgence in food and drink.

  • Warnings

  • Do not use

    if you have Hereditary Fructose Intolerance (HFI). This product cnotains fructose.

  • Ask a doctor before use if you

    • have diabetes because this product contains sugar
    • are on a sodium-restricted diet
  • Ask a doctor or pharmacist before use if you are

    taking any other medications. This product may interact with certain prescription drugs.

  • When using this product,

    do not take more than 16 tablets in a 24-hour period.

  • Stop use and ask a doctor if

    nausea lasts more than two weeks or recurs frequently.

  • If pregnant or breast-feeding,

    ask a health professional before use.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.

  • Directions

    • Adults: 2-4 tablets.
    • Children: Consult a doctor for appropriate dosage.
    • Chew tablets completely.
    • Dosage may be repeated after 15 minutes, not to exceed 16 tablets in a 24-hour period unless advised by a doctor.
    • Read all package directions and warnings before use and use only as directed.
    • Nauzene Chewables are intended for use by normally healthy persons only.
    • Persons under 18 years of age should use only as directed by a doctor.

  • Other information

    • Sodium content: 60 mg/tablet
    • Store at room temperature.
    • **Contents Sealed: Each round tan NAUZENE chewable tablet bears the identifying mark "ALVA" and is sealed in a clear plastic blister with a foil backing. Do not use if seal appears broken or if product contents do not match product description. Slight darker speckling may occur over time. Note: NAUZENE is not intended as a substitute for a balanced nutritional diet or as an electrolyte replensihment.
    • You may report serious side effects to the phone number provided under Questions? below.
  • Inactive ingredients

    Acacia, D&C Yellow No. 10 Lake, Dextrose, Flavors (natural and artificial), Fructose, Ginger root, Hydroxypropylcellulose, Magnesium stearate, Malic acid, Maltodextrin, Povidone, Silicon dioxide, Stearic acid, Stevia extract, Sucralose, Sucrose.

  • Questions?

    1-800-792-2582

  • PRINCIPAL DISPLAY PANEL

    PDP

  • INGREDIENTS AND APPEARANCE
    NAUZENE CHEWABLES  GINGER HONEY
    sodium citrate tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:52389-677
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID230 mg
    Inactive Ingredients
    Ingredient NameStrength
    DEXTROSE (UNII: IY9XDZ35W2)  
    POVIDONE K30 (UNII: U725QWY32X)  
    MALIC ACID (UNII: 817L1N4CKP)  
    STEVIA LEAF (UNII: 6TC6NN0876)  
    ACACIA (UNII: 5C5403N26O)  
    HYDROXYPROPYLCELLULOSE (UNII: 9XZ8H6N6OH)  
    SUCROSE (UNII: C151H8M554)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    SUCRALOSE (UNII: 96K6UQ3ZD4)  
    D&C YELLOW NO. 10 ALUMINUM LAKE (UNII: CQ3XH3DET6)  
    FRUCTOSE (UNII: 6YSS42VSEV)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    ZINGIBER OFFICINALE WHOLE (UNII: IN6Q3S3414)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    Product Characteristics
    ColoryellowScoreno score
    ShapeROUNDSize16mm
    FlavorGINGER (Ginger-Honey flavor) Imprint Code ALVA
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:52389-677-423 in 1 CARTON02/17/2025
    114 in 1 BLISTER PACK; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00102/17/2025
    Labeler - Kobayashi Healthcare International, Inc. (156391729)
    Registrant - Kobayashi America Manufacturing, LLC (079852150)